Q&A: What's behind the approvals? Research over decades produced a new generation of cancer therapies that are specifically targeted.

Published Date: 27 Dec 2023

The previous month, the U. s. The FDA has authorized the use of capivasertib in conjunction with fulvestrant, a current cancer treatment, for patients with the most common type of breast cancer.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Potential targets for treating the most common type of liver cancer in children have been identified by a collaborative study.

2.

Study identifies new approach to protect the brain during radiation therapy

3.

While most cancer screenings won't prolong lives, there are still good reasons to continue screening.

4.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

5.

Radiation therapy for patients with breast cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot